opioid overdose

Work Environment Factors and Prevention of Opioid-Related Deaths

Citation
William S. Shaw, Cora Roelofs, and Laura Punnett, 2020: Work Environment Factors and Prevention of Opioid-Related Deaths American Journal of Public Health 110, 1235_1241, https://doi.org/10.2105/AJPH.2020.305716
Publication Date

Opioid use disorder (OUD) and opioid overdose deaths (OODs) are prevalent among US workers, but work-related factors have not received adequate attention as either risk factors or opportunities for OOD prevention. Higher prevalence of OOD in those with heavy physical jobs, more precarious work, and limited health care benefits suggest work environment and organizational factors may predispose workers to the development of OUD.

Exploring Opioid Overdose Incidence in a Cohort of People Who Inject Drugs

Created by
NDARC

This seminar provides a preliminary examination of the range of information available on opioid overdose in Australia’s largest and only active cohort study of people who use drugs.

Penny Hill from the Burnet Institute explores a range of self-report and linked data including data collected on ambulance attendances, emergency department presentations and deaths.

Association of Disability With Mortality From Opioid Overdose Among US Medicare Adults

Citation
Kuo Y, Raji MA, Goodwin JS. Association of Disability With Mortality From Opioid Overdose Among US Medicare Adults. JAMA Netw Open. 2019;2(11):e1915638. doi:https://doi.org/10.1001/jamanetworkopen.2019.15638
Publication Date

Key Points

Question: What is the rate of opioid overdose deaths among Medicare enrollees younger than 65 years who qualified for Medicare because of disability?

Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial

Citation
Dietze P, Jauncey M, Salmon A, et al. Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial. JAMA Netw Open. 2019;2(11):e1914977. doi:https://doi.org/10.1001/jamanetworkopen.2019.14977
Publication Date

Key Points

Question: Is 800 μg of naloxone hydrochloride administered intranasally as effective in reversing opioid overdose as the same dose administered intramuscularly?

Are medical cannabis laws linked to less opioid overdose mortality? Results from a new study

Stanford, California, United States,

In 2014, a study by Bachhuber et al. showed that, in the USA, state-level medical cannabis laws were associated with lower-than-expected opioid overdose mortality rates from 1999 to 2010. A new study by Shover et al. using the same methodology, found that in the longer period the findings reversed. In fact, in both cases, the authors underline how this kind of study should not be used to make causal claims. 

Association between Medical Cannabis Laws and Opioid Overdose Mortality Has Reversed over Time

Citation
www.pnas.org/cgi/doi/10.1073/pnas.1903434116
Publication Date

Medical cannabis has been touted as a solution to the US opioid overdose crisis since Bachhuber et al. [M. A. Bachhuber, B. Saloner, C. O. Cunningham, C. L. Barry, JAMA Intern. Med. 174, 1668–1673] found that from 1999 to 2010 states with medical cannabis laws experienced slower increases in opioid analgesic overdose mortality.